{"schema_version":"secwatch.filing_event.v1","accession":"0001722482-24-000100","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.741673+00:00","generated_at":"2026-06-03T06:33:57.690417+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Avantor Q1 net sales fall 5.6% to $1.68B; net income down 50% to $60M","bullets":["Net sales $1.68B, -5.6% YoY; organic decline 6.3%. Net income $60M vs $121.5M prior year.","Diluted GAAP EPS $0.09, adjusted EPS $0.22; Adjusted EBITDA $283M.","Laboratory Solutions organic sales -4.5%; Bioscience Production organic -10.0%.","Operating cash flow $142M, free cash flow $107M; FY2024 guidance reaffirmed.","Adjusted net leverage 4.0x as of March 31, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001722482-24-000100","json":"https://secwatch.observer/filing/0001722482-24-000100.json","markdown":"https://secwatch.observer/filing/0001722482-24-000100.md","text":"https://secwatch.observer/filing/0001722482-24-000100.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000172248224000100/0001722482-24-000100-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000172248224000100/avtr-20240426.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:33:57.690417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a470b2848b7c779bc93765501bd25a9c98adafaa","claim":"Avantor, Inc. reported first fiscal quarter ended March 31, 2024 results: revenue $1.68 billion, net income $60.4 million, EPS $0.09. Guidance reaffirmed.","evidence_excerpt":"Act of 1933, except as expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Avantor® Reports First Quarter 2024 Results • Net sales of $1.68 billion, decrease of 5.6%; organic decline of 6.3% • Net income of $60 million; Adjusted EBITDA of $283 million • Diluted GAAP EPS of $0.09; adjusted EPS of $0.22 • Operating cash flow","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1722482/000172248224000100/0001722482-24-000100-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first fiscal quarter ended March 31, 2024"},{"label":"Revenue","value":"$1.68 billion"},{"label":"Net income","value":"$60.4 million"},{"label":"EPS","value":"$0.09"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}